H2020HORIZONFP7
Alzheimer Europe
- Country
- LULuxembourg
- Defence projects
- 0
- Projects, all programmes
- 35
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 6,018,169
- Active
- 2010 to 2025
Projects
35 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| AD Detect-PreventAlzheimer's Disease (AD) Detect & Prevent - Presymptomatic AD detection and prevention | H2020 | 2018 | Participant | EUR 68,250 |
| AMYPADAmyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 | H2020 | 2016 | Participant | EUR 222,750 |
| MOPEADModels Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 | H2020 | 2016 | Participant | EUR 91,275 |
| MinDDesigning for People with Dementia: designing for mindful self-empowerment and social engagement | H2020 | 2016 | Participant | EUR 0 |
| ROADMAPReal world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 | H2020 | 2016 | Participant | EUR 176,000 |
| EPADEuropean Prevention of Alzheimer’s Dementia Consortium | FP7 | 2015 | Participant | EUR 277,000 |
| SMART4MDSupport, Monitoring and Reminder Technology for Mild Dementia | H2020 | 2015 | Participant | EUR 67,620 |
| SyDADSynaptic Dysfunction in Alzheimer Disease | H2020 | 2015 | Partner | EUR 0 |
| AETIONOMYAetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy | FP7 | 2014 | Participant | EUR 99,000 |
| PACEComparing the effectiveness of palliative care for elderly people in long term care facilities in Europe | FP7 | 2014 | Participant | EUR 91,680 |
| PredictNDFrom Patient Data to Clinical Diagnosis in Neurodegenerative Diseases | FP7 | 2014 | Participant | EUR 118,800 |
| EMIFEuropean Medical Information Framework | FP7 | 2013 | Participant | EUR 48,700 |
| NILVADA European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease | FP7 | 2012 | Participant | EUR 33,599 |
| DECIDEDiagnostic Enhancement of Confidence by an International Distributed Environment | FP7 | 2010 | Participant | EUR 84,422 |
| PHARMA-COGPrediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical development | FP7 | 2010 | Participant | EUR 100,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.